Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 10/20 | 0.62 |
| ▸ | PPARD | Q03181 | 5/20 | 0.48 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.44 |
| ▸ | PTPRC | P08575 | 1/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP14 | P50281 | 1/20 | 0.41 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3907768 | 0.89 | PTPN1 (0.62) | PTPN1PPARDMRGPRX4FFAR1PTPRC | |
| SCHEMBL3909316 | 0.89 | PTPN1 (0.79) | PTPN1PTPRCPTPN2 | |
| SCHEMBL3907472 | 0.89 | PTPN1 (0.77) | PTPN1PPARDMRGPRX4FFAR1PTPRC | |
| SCHEMBL3909638 | 0.87 | PTPN1 (0.66) | PTPN1MRGPRX4 | |
| SCHEMBL3905232 | 0.87 | PTPN1 (0.61) | PTPN1 | |
| SCHEMBL3906135 | 0.86 | PTPN1 (0.60) | PTPN1PPARDMRGPRX4PTPRCPTPN2 | |
| SCHEMBL3907610 | 0.84 | PTPN1 (0.65) | PTPN1PTPRCPTPN2 | |
| SCHEMBL3909147 | 0.84 | PTPN1 (0.65) | PTPN1PPARDMRGPRX4FFAR1PTPRC | |
| SCHEMBL6265485 | 0.82 | PTPN1 (0.64) | PTPN1FFAR1PTPRCPTPN2 | |
| SCHEMBL3905151 | 0.80 | PTPN1 (0.58) | PTPN1PPARDFFAR1PTPRCPTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7521473-B2 | Inhibitors of protein tyrosine phosphatase 1B | WYETH (US) | 2009-04-21 | — | — | US | disclosed |
| US-20050203087-A1 | Inhibitors of protein tyrosine phosphatase 1B | WYETH | 2005-09-15 | — | — | US | disclosed |
| WO-2005081954-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | WYETH (US) | 2005-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203087-A1 | Inhibitors of protein tyrosine phosphatase 1B | PTPRO, PTPRS, PTPRM | PTPN1 11/4885PPARD 1414/4885MRGPRX4 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.